Showing results (1-10 of 19) with videos related to
Sort By:
Pageof 2
Canadian Journal of Microbiology|September 10, 2013
Impact of D-amino acid dehydrogenase on virulence factor production by a Pseudomonas aeruginosaKathryn E Oliver, Laura Silo-SuhExpert Opinion on Pharmacotherapy|June 28, 2023
The revolution of personalized pharmacotherapies for cystic fibrosis: what does the future hold?Kathryn E Oliver, Marianne S Carlon, Nicoletta Pedemonte, et al.Current Opinion in Pharmacology|October 17, 2017
Transformative therapies for rare CFTR missense allelesKathryn E Oliver, Sangwoo T Han, Eric J Sorscher, et al.Journal of Clinical & Translational Endocrinology|May 20, 2024
Racial inequities and rare <i>CFTR</i> variants: Impact on cystic fibrosis diagnosis and treatmentMalinda Wu, Jacob D Davis, Conan Zhao, et al.Biorxiv : the Preprint Server for Biology|October 24, 2023
Benchmarking AlphaMissense Pathogenicity Predictions Against Cystic Fibrosis VariantsEli Fritz McDonald, Kathryn E Oliver, Jonathan P Schlebach, et al.Frontiers in Genetics|May 11, 2023
Features of CFTR mRNA and implications for therapeutics developmentJaNise J Jackson, Yiyang Mao, Tyshawn R White, et al.Plos One|January 25, 2024
Benchmarking AlphaMissense pathogenicity predictions against cystic fibrosis variantsEli Fritz McDonald, Kathryn E Oliver, Jonathan P Schlebach, et al.International Journal of Neonatal Screening|October 24, 2025
<i>CFTR</i> Variant Frequencies and Newborn Screening Panel Performance in the Diverse CF Population Receiving Care in the State of GeorgiaEileen Barr, Brittany Truitt, Andrew Jergel, et al.International Journal of Neonatal Screening|October 24, 2025
Evaluating Georgia's Cystic Fibrosis Newborn Screening Algorithm to Inform Improvement RecommendationsBrittany Truitt, Eileen Barr, Angela Wittenauer, et al.BMC Genomics|July 17, 2019
Assessing cell-specific effects of genetic variations using tRNA microarraysChristine Polte, Daniel Wedemeyer, Kathryn E Oliver, et al.Pageof 2